Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Summit Therapeutics (SMMT)
NASDAQ:SMMT
Summit Therapeutics (SMMT) Ownership - Who Owns Summit Therapeutics?
276 Followers
Summit Therapeutics (SMMT) Ownership Overview
82.82% Insiders
1.50% Mutual Funds
3.16% Other Institutional Investors
12.52% Public Companies and
Individual Investors
The ownership structure of Summit Therapeutics (SMMT) stock is a mix of institutional, retail and individual investors. Approximately 4.65% of the company’s stock is owned by Institutional Investors, 82.82% is owned by Insiders and 12.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 27, 2024 | Maky Zanganeh Ceo,director | Bought | $411094 |
| Mar 27, 2024 | Bought | $375000 | |
| Dec 13, 2023 | Maky Zanganeh Ceo,director | Bought | $1204108 |
| Dec 13, 2023 | Maky Zanganeh Ceo,director | Bought | $10350 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,728,944 | Institution | 0.96% | 27,857,828 | |
| 5,778,730 | Institution | 0.82% | 23,923,942 | |
| 5,506,968 | Institution | 0.78% | 22,798,848 | |
| 5,495,444 | Institution | 0.78% | 22,751,138 | |
| 3,140,473 | Institution | 0.45% | 13,001,558 | |
| 1,471,205 | Institution | 0.21% | 6,090,789 | |
| 1,234,345 | Institution | 0.18% | 5,110,188 | |
| 670,950 | Institution | 0.10% | 2,777,733 | |
| 650,286 | Institution | 0.09% | 2,692,184 | |
| 537,522 | Institution | 0.08% | 2,225,341 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,495,444 | Institution | 0.78% | 22,751,138 | |
| 1,471,205 | Institution | 0.21% | 6,090,789 | |
| 1,234,345 | Institution | 0.18% | 5,110,188 | |
| 537,522 | Institution | 0.08% | 2,225,341 | |
| 468,085 | Institution | 0.07% | 1,937,872 | |
| 320,060 | Institution | 0.05% | 1,325,048 | |
| 311,328 | Institution | 0.04% | 1,288,898 | |
| 77,925 | Institution | 0.01% | 322,610 | |
| 77,616 | Institution | 0.01% | 321,330 | |
| 76,500 | Institution | 0.01% | 316,710 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,349,488 | Institution | 0.76% | 20,060,580 | |
| 3,662,182 | Institution | 0.52% | 16,626,306 | |
| 2,836,135 | Institution | 0.40% | 11,741,599 | |
| 1,854,075 | Institution | 0.26% | 8,417,501 | |
| 1,004,964 | Institution | 0.14% | 4,160,551 | |
| 629,334 | Institution | 0.09% | 2,605,443 | |
| 593,266 | Institution | 0.08% | 2,224,748 | |
| 474,706 | Institution | 0.07% | 2,155,165 | |
| 494,924 | Institution | 0.07% | 2,048,985 | |
| 423,772 | Institution | 0.06% | 1,923,925 |
FAQ
Who Owns Summit Therapeutics (SMMT)?
According to the latest TipRanks data, approximately 3.16% of the company's stock is held by institutional investors, 82.82% is held by insiders, and 12.52% is held by retail investors.
What percentage of Summit Therapeutics (SMMT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.16% of Summit Therapeutics (SMMT) stock is held by institutional investors.
What percentage of Summit Therapeutics (SMMT) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.52% of Summit Therapeutics (SMMT) stock is held by retail investors.
Who owns the most shares of Summit Therapeutics (SMMT)?
Vanguard owns the most shares of Summit Therapeutics (SMMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.